MEN1 and multiple endocrine neoplasia type 1: The suspicion of MEN1 syndrome emerged at significantly earlier age in MEN1 mutation carriers compared to non-carriers (31.4 ± 12.6 vs. 40.2 ± 17.3 years, p = 0.019, Table 1).